Kanda Mutsuo, Kitamura Koichi, Saito Akira, Hayashi Koichi, Suzuki Toshihiko
Department of Nephrology, Tokyo Medical University, Tokyo, JPN.
Department of Nephrology, Diabetes, and Endocrinology, Tokyo Bay Urayasu Ichikawa Medical Center, Urayasu, JPN.
Cureus. 2024 Apr 22;16(4):e58772. doi: 10.7759/cureus.58772. eCollection 2024 Apr.
Thrombocytopenia, anasarca (edema, pleural effusion, and ascites), fever, reticulin fibrosis/renal dysfunction, and organomegaly (TAFRO) syndrome is a rare and severe systemic disease. The emergence of thrombocytopenia, however, may be preceded by other signs or symptoms, which could delay the diagnosis of the disease. We reported a case in which an increased immature platelet fraction (IPF), a surrogate marker for megakaryocytic activity, preceded the development of thrombocytopenia, and finally, we diagnosed the patient with TAFRO syndrome. A 79-year-old male with a previous history of uninephrectomy due to bladder and ureteral cancer was admitted to our hospital because of massive edema and progressive impairment in renal function. On admission, inguinal lymphadenopathy, elevated C-reactive protein (CRP), bilateral pleural effusion, and ascites were observed, and the lymph node biopsy showed that atrophic lymphoid follicles and germinal centers were observed along with prominent glomeruloid vascular proliferation and the expansion of the interfollicular spaces consistent with the feature of Castleman's disease. The peripheral platelet count did not reach the level of the criteria for TAFRO syndrome (13.9×10/µL), but the immature platelet fraction was increased (11.6%), and bone marrow biopsy revealed hyperplasia of megakaryocytes. During the course of the preemptive treatment with prednisolone and tocilizumab, thrombocytopenia was uncovered, and the patient was finally diagnosed as having TAFRO syndrome. Thus, the present case may offer valuable information on the role of the immature platelet fraction in the establishment of the early diagnosis of TAFRO syndrome.
血小板减少、全身性水肿(水肿、胸腔积液和腹水)、发热、网状纤维组织增生/肾功能不全和器官肿大(TAFRO)综合征是一种罕见且严重的全身性疾病。然而,血小板减少的出现可能先于其他体征或症状,这可能会延迟疾病的诊断。我们报告了一例病例,其中巨核细胞活性的替代标志物未成熟血小板分数(IPF)升高先于血小板减少的发生,最终,我们诊断该患者患有TAFRO综合征。一名79岁男性,既往因膀胱癌和输尿管癌行单侧肾切除术,因大量水肿和肾功能进行性损害入住我院。入院时,观察到腹股沟淋巴结肿大、C反应蛋白(CRP)升高、双侧胸腔积液和腹水,淋巴结活检显示萎缩的淋巴滤泡和生发中心,同时伴有明显的肾小球样血管增生和滤泡间间隙增宽,符合Castleman病的特征。外周血小板计数未达到TAFRO综合征的标准水平(13.9×10⁹/µL),但未成熟血小板分数升高(11.6%),骨髓活检显示巨核细胞增生。在使用泼尼松龙和托珠单抗进行预防性治疗的过程中,发现了血小板减少,该患者最终被诊断为TAFRO综合征。因此,本病例可能为未成熟血小板分数在TAFRO综合征早期诊断中的作用提供有价值的信息。